Estrella Immunopharma ESLA
NASDAQ ESLA
$0.79 +0.05 (+6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Estrella Immunopharma (ESLA) Preferred Dividend Payments (2022 - 2023)

Updated

Analysis

Estrella Immunopharma (ESLA) Preferred Dividend Payments (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Estrella Immunopharma 32.66 Mn 27.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 209,733.00
Dec 31, 2022 123,793.00
Mar 31, 2022 4.64 Mn
API Access

Estrella Immunopharma Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=ESLA&period=max&api_key=YOUR_API_KEY